Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Number of shares outstanding for Seagen (SGEN)
Number of shares outstanding as of April 2024 : 188,135,000
According to Seagen 's latest financial reports and stock price the company's current number of shares outstanding is 188,135,000. At the end of 2023 the company had 188,135,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Seagen from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.18 B | 1.1% |
| 2022 | 0.18 B | 1.64% |
| 2021 | 0.18 B | 2.24% |
| 2020 | 0.17 B | 4.33% |
| 2019 | 0.17 B | 7.14% |
| 2018 | 0.16 B | 11.2% |
| 2017 | 0.14 B | 1.55% |
| 2016 | 0.14 B | 1.67% |
| 2015 | 0.13 B | 12.61% |
| 2014 | 0.12 B | 1.15% |
| 2013 | 0.12 B | 2.68% |
| 2012 | 0.11 B | 3.67% |
| 2011 | 0.11 B | 13.44% |
| 2010 | 0.10 B | 0.81% |
| 2009 | 0.10 B | 26.13% |
| 2008 | 79.78 M | 18.23% |
| 2007 | 67.48 M | 32.2% |
| 2006 | 51.05 M | 20.46% |
| 2005 | 42.37 M | 1% |
| 2004 | 41.95 M | 35.31% |
| 2003 | 31 M | 1.82% |
| 2002 | 30.45 M | 5.16% |
| 2001 | 28.96 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 2,901.57% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 838.66% | 🇺🇸 USA |
 Biogen BIIB | 144,800,000 | -23.03% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,057,000,000 | 993.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | 977.95% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | 201,918,066 | 7.33% | 🇺🇸 USA |
 ImmunoGen
IMGN | 273,341,000 | 45.29% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 47,261,000 | -74.88% | 🇺🇸 USA |